Related Experiment Videos
Safe prescribing practices in pregnancy and lactation
Wendy F Hansen1, Anne E Peacock, Jerome Yankowitz
1University of Iowa Hospitals and Clinics, USA.
Journal of Midwifery & Women'S Health
|December 18, 2002
Summary
Healthcare providers can navigate medication use during pregnancy by understanding drug teratology and FDA categories. This guide helps select safe pharmacologic agents for common conditions in pregnant women.
Area of Science:
- Obstetrics and Gynecology
- Pharmacology
- Teratology
Background:
- Pregnant individuals often require pharmacologic treatment for various conditions.
- Healthcare providers face challenges in selecting safe medications during pregnancy.
- Understanding drug effects on fetal development is crucial.
Purpose of the Study:
- To provide guidance on the safe use of medications during pregnancy.
- To review teratogenic risks associated with common drugs.
- To inform healthcare providers about FDA drug categorization for pregnant patients.
Main Methods:
- Review of teratology principles related to drug exposure.
- Analysis of FDA drug categorization for safety in pregnancy.
- Evidence-based review of common medications for specific conditions.
Main Results:
- Identification of drugs to be used or avoided during pregnancy based on teratogenic data.
- Specific recommendations for pharmacologic agents in treating respiratory, pain, GI, psychiatric, and neurologic conditions.
- Current evidence presented for recommended agents in each category.
Conclusions:
- Knowledge of teratology and FDA categories aids in safe medication selection for pregnant women.
- Evidence-based recommendations support optimal pharmacologic management during pregnancy.
- This resource assists healthcare providers in addressing medication dilemmas in pregnant patients.